4.3 Review

WHAT IS THE ROLE OF SUGAMMADEX IN THE EMERGENCY DEPARTMENT?

Journal

JOURNAL OF EMERGENCY MEDICINE
Volume 60, Issue 1, Pages 44-53

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jemermed.2020.08.006

Keywords

rapid sequence intubation; airway management; sugammadex; rocuronium; neuromuscular blockade

Ask authors/readers for more resources

Sugammadex is a newly available medication that rapidly reverses neuromuscular blockade. It can facilitate urgent neurological examinations, but its routine use in failed or difficult airway management is not supported by literature. It is important to prioritize oxygenation and ventilation in such situations.
Background: Sugammadex is a medication newly available to many emergency physicians. It effectively, and within minutes, reverses neuromuscular blockade in patients who have received rocuronium or vecuronium. The role of sugammadex for the reversal of neuromuscular blockade after rapid sequence intubation in the emergency department (ED) is evolving, and limited emergency medicine-specific literature exists. Objective: This narrative review evaluates the role of sugammadex for the reversal of neuromuscular blockade in the ED. Discussion: The basic pharmacology, duration of action, adverse effects, and important medication and disease interactions specific to sugammadex are well described. Case reports suggest sugammadex can reverse neuromuscular blockade to facilitate an urgent, neurologic examination by an emergency physician or consultant. Multiple case reports of failure to improve airway patency with the use of sugammadex, even when neuromuscular blockade is completely reversed, and concern for added difficulty of definitive airway management in a patient with spontaneous movement suggest that sugammadex should largely be omitted from failed or difficult airway management strategies. Instead, it is important to focus on the ability to oxygenate and ventilate, including progression to surgical airway or jet ventilation if needed. Conclusion: Sugammadex is an effective, rapid reversal agent for rocuronium and has the potential use to facilitate an urgent neurologic examination shortly after administration of rocuronium. Its routine inclusion in a failed or difficult emergency airway is not supported by available literature. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available